Hypersensitivity D006967

Diseases [C] » Immune System Diseases [C20] » Hypersensitivity

Description

Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.   MeSH

Subtype Terms (9)

Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
12 drugs (9 approved, 3 experimental)

Drug Hypersensitivity
5 drugs (4 approved, 1 experimental)

Environmental Illness
1 experimental drug

Hypersensitivity, Delayed
4 drugs (2 approved, 2 experimental)

Hypersensitivity, Immediate
16 drugs (8 approved, 8 experimental)

Immune Complex Diseases
1 approved drug



Organization Involved with Phase 4 Indications (91)

Organization Involved with Phase 3 Indications (95)

Organization Involved with Phase 2 Indications (149)

Organization Involved with Other Experimental Indications (100)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.